A New Approach in Tackling Coronavirus; MNA Liquid Medicine, a fumigant to kill COVID-19 deep inside the lungs

With confirmed COVID-19 cases surpassing 4 million across the world and continuing to grow, virologists, scientists and researchers are pushing forward with efforts to develop vaccines and identify treatments to slow the pandemic and mitigate the impact of the virus on both human health and the economy. To achieve this, many have turned to repurposing existing treatments for other viruses, like Remdesivir which was originally developed to block the development of Ebola and MERS, or Kaletra, a combination of two drugs developed to fight against HIV.

Unfortunately, each attempted treatment has delivered inconsistent outcomes, and in the worst cases - like that of hydroxychloroquine - caused negative side-effects that worsen symptoms and increase the mortality rate of COVID-19. Luckily, a number of innovators are pivoting to focus their varied expertise in identifying and developing a range of potential solutions to tackle the COVID-19 crisis. Better still, many of these treatments are all-natural which means that once development is complete, the alternate medicines are accessible much faster and easier than their Western Medicine counterparts.

“The MNA Liquid Medicine was developed to address the COVID-19 virus at a base level, that of contamination,” says Tara Chand, Inventor and CEO of Internet Promise Group. Health division, IPG Natural Health, is dedicated to developing treatments for health issues that western medicine cannot effectively treat. “The concept was realized by drawing inspiration from methods for removing a virus or other contaminating agent from a physical space, which had me watching videos of people dressed in protective gear fumigating the interior of a commercial aircraft. This made me wonder whether we could do something similar to an infected persons’ lungs.”

Inspired by these videos, Chand identified that a nebulizer would be the best vehicle to atomize a liquid medicine into vapor using ultrasonic-mesh technology and began researching compounds with the potential to clear the lungs of COVID-19. Unlike President Trump’s misguided musings around using bleach as an agent to rid the human body of the virus, Chand utilized his deep knowledge of Indian botanical compounds to identify three safe ingredients with acute antiviral and antibacterial complex compounds. These compounds, when combined and nebulized, have the potential to fumigate the lungs, ridding them of infection and restoring normal lung function.

Chand has filed a patent application for the treatment, naming it the DADR-Nebulizer-MNA Liquid Medicine, and is now seeking FDA approval to begin human trials. “We’re also seeking investors to help bring the medicine to market. Once we can secure the additional funding, we should be able to release the MNA Liquid Medicine within a few weeks,” says Chand. Given the time, red tape, and stringent testing required to develop a vaccine through Western Medicine methods, the potential for a fast rollout of Chand’s solution provides a little hope in a foreseeably bleak future.

The MNA Liquid Medicine isn’t Chand’s first foray into medicine, with the Innovator having produced - and patented - an effective treatment for middle-ear infections. Named ‘Ear Natural’, the treatment consists of a simple, single-use sachet filled with an all-natural mustard seed solution, which studies show hold effective antibacterial and antimicrobial properties.

“The design is what makes Ear Natural a unique and efficient solution to middle-ear infections,” says Chand, “The sachet is an all-in apparatus that, once heated for 30 seconds in the microwave has a built-in neck that fits comfortably in the ear canal to release the warmed mustard seed solution. This method can provide relief from ear infections in minutes, negating the need for doctors’ visits or antibiotics.”

With more than 50 approved patents under his belt and hundreds more pending, Chand’s intellect and innovative capacity isn’t limited to just one market vertical. In fact, he thrives on solving difficult problems in whatever capacity they may arise. While working on a solution for the COVID-19 crisis, he’s also secured a patent for GPS Smart, a miniscule firmware that blocks up to 90 percent of unnecessary RF radiation by calibrating a smartphone’s output to the user;s movement.

“Phones are constantly pinging cell phone towers with location signals, which causes a spike in RF radiation emissions. This is something that’s totally unnecessary when a phone is stationary,” says Chand, “To reduce the amount of RF radiation smartphone users are exposed to, while also extending battery life up to 80 percent, I created a firmware that uses GPS technology to only send location transmissions when a phone has moved more than 100 feet.”

In an effort to fast-track the rollout of this technology, Chand is urging the US, European, Canadian, Indian and Chinese government to facilitate the implementation of the GPS Smart firmware in new phone builds. He has also offered the firmware to the largest phone manufacturers in the world - Apple and Samsung - “at a fair price” to help safeguard device users against the potentially harmful effects of RF radiation.

The GPS Smart technology is added to Chand’s Internet Promise Group portfolio which, under his guidance and intellect, has developed and marketed proprietary mobile, security and information systems and platforms that secure transactions, authenticate identity, protect privacy, increase safety and save lives. Internet Promise group has licensed its technology to Motorola, Nokia, Mitsubishi, Sony, Logitech and more.

This article does not necessarily reflect the opinions of the editors or management of EconoTimes